Health ❯ Healthcare ❯ Clinical Research

Drug Trials

Efficacy Studies Semaglutide for Smoking Cessation Eli Lilly Semaglutide and Cardiovascular Outcomes Wegovy Study Novo Nordisk Study Side Effects Lecanemab Gepotidacin Study Rapamycin Effects Liraglutide and Semaglutide Comparative Effectiveness Research Randomized Controlled Trials Pancreatitis Cases GLP-1RA Studies Eli Lilly's Kisunla Real-World Studies Autoimmune Disorders Late-Stage Studies Personalized Treatments Niraparib Study Observational Studies BCL2 Inhibitors Weight Loss Studies Semaglutid Regulatory Approvals Combination Therapy Side Effects Monitoring

FDA Clears Enhertu-Perjeta Combo for First-Line HER2-Positive Metastatic Breast Cancer

The decision follows phase 3 results showing a roughly 14-month median progression-free survival advantage over the THP regimen.

Sanofi, Dren Bio Set Autoimmune Collaboration Worth Up to $1.7 Billion With $100 Million Upfront

AbbVie Extends Rinvoq U.S. Exclusivity to 2037 as AI Biotechs Move From Models to Medicines